Market Trends of Global Disposable Blood Bags Industry
Blood Transfusion Bags is Expected to Witness Significant Growth Over the Forecast Period
Blood transfusion bags hold blood or its components, like red blood cells or plasma. These bags are connected to a thin tube and inserted into a vein, allowing the blood products to flow directly into the human body.
The blood transfusion bags segment is anticipated to hold a significant market share over the forecast period. Factors such as the growing number of surgical procedures such as cardiac surgery, vascular surgery, and others that require a blood transfusion to recover the blood loss during surgical procedures are expected to boost segment growth. In addition, the increasing prevalence of blood-related and chronic conditions such as hemophilia, anemia, and thalassemia require regular blood transfusions, further propelling the demand for disposable blood transfusion bags in the market.
The increasing need for blood transfusions, owing to the growing aging population, complex surgeries, and improved trauma care, creates a direct demand for blood transfusion bags across healthcare facilities. For instance, according to the article published by Starpearls in June 2023, around 5 million Americans require a blood transfusion each year for acute blood loss, surgery, hemophilia, or cancer. As the number of blood transfusions rises, the demand for blood transfusion bags inevitably increases. Thus, with the rising cases of blood transfusion, the studied segment is anticipated to grow over the forecast period.
Moreover, manufacturers aim to reach more customers and expand their market share by adopting effective distribution channels and acquisition strategies. For instance, in January 2022, SpotSee signed the acquisition of the assets of Biosynergy, Inc., a medical device manufacturer. This acquisition aims to strengthen the company's goal of reducing product damage by incorporating blood temperature monitoring devices in blood bags, which can further improve product supply and cold chain. Such developments are anticipated to boost segment growth during the forecast period.
Thus, the factors above, such as the rising cases of blood transfusion and manufacturers focusing on strategies such as acquisition, are expected to increase the segment growth, thereby boosting the market growth over the forecast period.
North America Holds a Significant Share in the Market and Do the Same during the Forecast Period
Some of the factors driving the market growth in the North American region include the increasing prevalence of blood-related disorders coupled with the elderly population, the rising burden of road accidents and injuries, and new product launches.
Elderly individuals are more likely to require a blood transfusion due to chronic health conditions that require surgical procedures, hence raising the demand for safe and readily available blood supplies in the United States. Also, the demand for blood is increasing across the region, propelling the need for various disposable blood bags to collect and transport blood from one place to another. For instance, according to the data published by the American National Red Cross 2024 update, approximately 29,000 red blood cells, nearly 5,000 platelets, and 6,500 plasma units are needed daily in the United States. About 16 million blood components are transfused each year in the United States.
Furthermore, the burden of road accidents has propelled the demand for blood supply during surgical procedures as well as to recover the blood loss. For instance, according to the data published by Fatal Car Crash Statistics 2024, about 42,795 fatal car crashes were reported in the United States in 2022.
The rising prevalence of anemia, leukemia, thalassemia, and hemophilia among the population necessitates frequent blood transfusions to patients to replenish red blood cells and improve oxygen delivery throughout the body. For instance, according to the American Cancer Society, in January 2024, about 62,770 new cases of leukemia and 8,570 new cases of Hodgkin lymphoma were expected to be diagnosed in the United States. Additionally, according to the 2023 updated data published by Leukemia and Lymphoma, about 184,720 new leukemia, lymphoma, and myeloma cases were recorded in the United States in 2023.
Furthermore, according to the data published by Canadian Cancer Statics in 2023, about 239,100 Canadians were diagnosed with cancer in 2022. Hence, the rising prevalence of anemia, leukemia, and thalassemia is a significant factor driving the demand for disposable blood bags due to the increased need for blood transfusions and blood component therapy, contributing to the market growth.
Therefore, owing to the factors mentioned above, such as the growing blood test counts among patients, rising blood transfusion, growing cases of road accidents, and increasing cases of leukemia, lymphoma, and myeloma in the region, the growth of the market is anticipated to increase in the North American region over the forecast period.
